We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$18.4B
AUM Growth
+$120M
Cap. Flow
+$64.5M
Cap. Flow %
0.35%
Top 10 Hldgs %
43.98%
Holding
252
New
8
Increased
28
Reduced
110
Closed
4

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$285M
2
UNH icon
UnitedHealth
UNH
+$53.5M
3
GE icon
GE Aerospace
GE
+$36.4M
4
PEP icon
PepsiCo
PEP
+$12.5M
5
RL icon
Ralph Lauren
RL
+$10.1M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$39.4M
2
PM icon
Philip Morris
PM
+$20.6M
3
AAPL icon
Apple
AAPL
+$18.7M
4
KO icon
Coca-Cola
KO
+$17.7M
5
MO icon
Altria Group
MO
+$13.8M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.84%
2 Energy 18.16%
3 Financials 14.69%
4 Healthcare 10.53%
5 Technology 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
51
GE Aerospace
GE
$364B
$92M 0.5%
647,797
+244,034
+60% +$36.4M
APD icon
52
Air Products & Chemicals
APD
$65.7B
$90M 0.49%
654,516
-21,424
-3% -$2.97M
CELG
53
DELISTED
Celgene Corp
CELG
$86.9M 0.47%
832,134
-28,700
-3% -$3.11M
ICE icon
54
Intercontinental Exchange
ICE
$87.3B
$85.2M 0.46%
1,583,365
-23,090
-1% -$1.26M
NKE icon
55
Nike
NKE
$64.1B
$76.9M 0.42%
1,460,877
+148,676
+11% +$8.39M
WMT icon
56
Walmart Inc
WMT
$909B
$76M 0.41%
3,161,484
-22,140
-0.7% -$537K
ASML icon
57
ASML
ASML
$596B
$73.5M 0.4%
671,200
-39,125
-6% -$4.14M
WFC icon
58
Wells Fargo
WFC
$254B
$73M 0.4%
1,652,654
-74,634
-4% -$3.57M
DEO icon
59
Diageo
DEO
$49.6B
$71.8M 0.39%
618,926
-4,222
-0.7% -$483K
INTC icon
60
Intel
INTC
$413B
$70.4M 0.38%
1,864,469
+1,548
+0.1% +$54.8K
PSX icon
61
Phillips 66
PSX
$82.9B
$67.2M 0.37%
833,648
-7,172
-0.9% -$557K
ORCL icon
62
Oracle
ORCL
$339B
$66.4M 0.36%
1,691,690
-98,272
-5% -$4M
K
63
DELISTED
Kellanova
K
$59.3M 0.32%
815,665
+1,598
+0.2% +$122K
BRK.A icon
64
Berkshire Hathaway Class A
BRK.A
$1.1T
$56M 0.3%
259
-3
-1% -$658K
UNH icon
65
UnitedHealth
UNH
$382B
$53.3M 0.29%
+381,762
New +$53.5M
IBM icon
66
IBM
IBM
$214B
$46.3M 0.25%
305,104
-827
-0.3% -$126K
RDS.A
67
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$45.7M 0.25%
912,734
-117,643
-11% -$6M
KMPR icon
68
Kemper
KMPR
$1.81B
$41.3M 0.23%
1,051,444
TFCF
69
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$38.3M 0.21%
1,547,864
-50,445
-3% -$1.31M
STZ icon
70
Constellation Brands
STZ
$22.5B
$34.5M 0.19%
207,434
+2,193
+1% +$362K
HD icon
71
Home Depot
HD
$337B
$33.7M 0.18%
262,072
-5,427
-2% -$723K
VRSN icon
72
VeriSign
VRSN
$26.3B
$28.6M 0.16%
364,844
-15,648
-4% -$1.26M
Z icon
73
Zillow
Z
$7.78B
$27.2M 0.15%
786,240
ESRX
74
DELISTED
Express Scripts Holding Company
ESRX
$26.2M 0.14%
371,410
-500
-0.1% -$37.4K
PFE icon
75
Pfizer
PFE
$144B
$22.3M 0.12%
692,598
-12,327
-2% -$412K

Similar funds

Fayez Sarofim & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Fayez Sarofim & Co held 252 positions worth $18.4B, up 0.66% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 4.8%. Fayez Sarofim & Co opened 8 new positions and exited 4, leaving the 252-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, down from 34% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q3 2016 buy was UnitedHealth: 381,762 shares worth $53.3M.
  • Fayez Sarofim & Co added most to ExxonMobil in Q3 2016, an estimated $285M increase.
  • Fayez Sarofim & Co's biggest Q3 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $39.4M.
  • Fayez Sarofim & Co fully exited Rio Tinto in Q3 2016, selling an estimated $382K.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $18.4B portfolio in Q3 2016.
  • Fayez Sarofim & Co opened 8 new positions and closed 4 in Q3 2016.
  • Fayez Sarofim & Co's portfolio value rose 0.66% quarter-over-quarter to $18.4B.

Based on Fayez Sarofim & Co's 13F filing for Q3 2016, filed 14 Nov 2016.